Literature DB >> 23179499

Pelvic floor disorders among women in Dabat district, northwest Ethiopia: a pilot study.

Berihun Megabiaw1, Mulatu Adefris, Guri Rortveit, Getu Degu, Mulu Muleta, Astrid Blystad, Torvid Kiserud, Tesfahun Melese, Yigzaw Kebede.   

Abstract

INTRODUCTION AND HYPOTHESIS: Pelvic floor disorders affect many women in high-income countries. Since little is known about such disorders in Africa, this study aimed at assessing the prevalence and risk factors in an Ethiopian community. We also assessed the validity of a prolapse questionnaire.
METHODS: A community-based cross-sectional study was conducted among 395 women, recruited by a systematic random sampling technique. Women were interviewed about symptoms of urinary incontinence, faecal incontinence and pelvic organ prolapse by female nurses. Additionally, pelvic examinations were performed in 294 (74.2%) participants to assess anatomical prolapse using the simplified Pelvic Organ Prolapse Quantification staging system. Descriptive statistics and logistic regression analyses were employed.
RESULTS: The median age of participants was 35.0 years. Thirty-one women reported urinary incontinence (7.8%), 25 (6.3%) symptomatic pelvic organ prolapse and 2 (0.5%) faecal incontinence. Anatomical pelvic organ prolapse stage II-IV was detected in 162 (55.1%) of women who underwent pelvic examination. The questionnaire for prolapse assessment had poor validity (38.3% sensitivity and 95.4% specificity) even in cases of clinically relevant prolapse (stage III or IV). After adjustment, carrying heavy objects for 5 or more hours a day, history of prolonged labour and highland rural residence were associated with anatomical pelvic organ prolapse.
CONCLUSIONS: Self-reported incontinence seems low in northwest Ethiopia. The prevalence of symptomatic prolapse was low despite a high prevalence of prolapse signs. Notably, heavy carrying and prolonged labour increased the risk of anatomical prolapse stage II-IV. The methods of assessing pelvic floor disorders in a low-income context need further development.

Entities:  

Mesh:

Year:  2012        PMID: 23179499     DOI: 10.1007/s00192-012-1981-y

Source DB:  PubMed          Journal:  Int Urogynecol J        ISSN: 0937-3462            Impact factor:   2.894


  26 in total

1.  Epidemiology of pelvic organ prolapse in rural Gambia, West Africa.

Authors:  Caroline Scherf; Linda Morison; Alison Fiander; Gloria Ekpo; Gijs Walraven
Journal:  BJOG       Date:  2002-04       Impact factor: 6.531

2.  Prevalence and burden of fecal incontinence: a population-based study in women.

Authors:  Adil E Bharucha; Alan R Zinsmeister; G Richard Locke; Barbara M Seide; Kimberly McKeon; Cathy D Schleck; L Joseph Melton
Journal:  Gastroenterology       Date:  2005-07       Impact factor: 22.682

3.  Age- and type-dependent effects of parity on urinary incontinence: the Norwegian EPINCONT study.

Authors:  G Rortveit; Y S Hannestad; A K Daltveit; S Hunskaar
Journal:  Obstet Gynecol       Date:  2001-12       Impact factor: 7.661

Review 4.  Pelvic organ prolapse and incontinence in developing countries: review of prevalence and risk factors.

Authors:  Godfrey J A Walker; Prasanna Gunasekera
Journal:  Int Urogynecol J       Date:  2010-07-09       Impact factor: 2.894

5.  A severity index for epidemiological surveys of female urinary incontinence: comparison with 48-hour pad-weighing tests.

Authors:  H Sandvik; A Seim; A Vanvik; S Hunskaar
Journal:  Neurourol Urodyn       Date:  2000       Impact factor: 2.696

6.  Prevalence and the associated trigger factors of urinary incontinence among 5000 black women in sub-Saharan Africa: findings from a community survey.

Authors:  Oladosu A Ojengbede; Imran O Morhason-Bello; Babatunde O Adedokun; Ngozi S Okonkwo; Charles O Kolade
Journal:  BJU Int       Date:  2011-03-25       Impact factor: 5.588

Review 7.  An International Urogynecological Association (IUGA)/International Continence Society (ICS) joint report on the terminology for female pelvic floor dysfunction.

Authors:  Bernard T Haylen; Dirk de Ridder; Robert M Freeman; Steven E Swift; Bary Berghmans; Joseph Lee; Ash Monga; Eckhard Petri; Diaa E Rizk; Peter K Sand; Gabriel N Schaer
Journal:  Int Urogynecol J       Date:  2009-11-25       Impact factor: 2.894

8.  Racial differences in pelvic organ prolapse.

Authors:  Emily L Whitcomb; Guri Rortveit; Jeanette S Brown; Jennifer M Creasman; David H Thom; Stephen K Van Den Eeden; Leslee L Subak
Journal:  Obstet Gynecol       Date:  2009-12       Impact factor: 7.661

9.  Prevalence and risk factors for urinary and fecal incontinence in Brazilian women.

Authors:  Joao L Amaro; Carlos A Macharelli; Hamilto Yamamoto; Paulo R Kawano; Carlos V Padovani; Aparecido D Agostinho
Journal:  Int Braz J Urol       Date:  2009 Sep-Oct       Impact factor: 1.541

10.  Symptomatic pelvic organ prolapse: prevalence and risk factors in a population-based, racially diverse cohort.

Authors:  Guri Rortveit; Jeanette S Brown; David H Thom; Stephen K Van Den Eeden; Jennifer M Creasman; Leslee L Subak
Journal:  Obstet Gynecol       Date:  2007-06       Impact factor: 7.661

View more
  28 in total

1.  Polymorphism rs1800255 from COL3A1 gene and the risk for pelvic organ prolapse.

Authors:  Fernando Henrique Teixeira; César Eduardo Fernandes; Ricardo Peres do Souto; Emerson de Oliveira
Journal:  Int Urogynecol J       Date:  2019-04-30       Impact factor: 2.894

2.  Validation of the Amharic version of the Pelvic Organ Prolapse Symptom Score (POP-SS).

Authors:  Tadesse Belayneh; Abebaw Gebeyehu; Mulat Adefris; Guri Rortveit; Tinsae Genet
Journal:  Int Urogynecol J       Date:  2018-11-21       Impact factor: 2.894

3.  Vaginal pessaries in the management of symptomatic pelvic organ prolapse in rural Kilimanjaro, Tanzania: a pre-post interventional study.

Authors:  Benjamin C Shayo; Gileard G Masenga; Vibeke Rasch
Journal:  Int Urogynecol J       Date:  2018-08-18       Impact factor: 2.894

4.  Development and initial validation of a pictorial survey to assess for symptomatic pelvic organ prolapse and urinary incontinence in western Kenya.

Authors:  Michele O'Shea; Jackton Omoto; Megan Huchko; Stephen Gwer
Journal:  Int Urogynecol J       Date:  2022-06-30       Impact factor: 1.932

5.  Factors Associated With Persistent Urinary Incontinence Among Women Undergoing Female Genital Fistula Surgery in the Democratic Republic of Congo From 2017 to 2019.

Authors:  Dolores Nembunzu; Naomie Mayemba; Sidikiba Sidibé; Fassou Mathias Grovogui; Brian Tena Tena Aussak; Don Félicien Banze Kyongolwa; Bienvenu Salim Camara; Vandana Tripathi; Alexandre Delamou
Journal:  Front Glob Womens Health       Date:  2022-06-24

6.  Silently waiting to heal: experiences among women living with urinary incontinence in northwest Ethiopia.

Authors:  Janne L Gjerde; Guri Rortveit; Mulu Muleta; Astrid Blystad
Journal:  Int Urogynecol J       Date:  2012-11-06       Impact factor: 2.894

7.  Strengthening validity in studies of pelvic floor disorders through qualitative research: an example from Ethiopia.

Authors:  Astrid Blystad; Guri Rortveit; Janne Lillelid Gjerde; Mulu Muleta; Karen Marie Moland
Journal:  Int Urogynecol J       Date:  2017-11-18       Impact factor: 2.894

8.  Women's experiences and perception of symptomatic pelvis organ prolapse: A Cross sectional study from Uttarakhand, India.

Authors:  Shashi Prateek; Rajlaxmi Mundhra; Anupama Bahadur; Kiran Kunwar; Prerna Jha; Latika Chawla
Journal:  J Family Med Prim Care       Date:  2021-01-30

9.  Uterine prolapse and associated factors among reproductive-age women in south-west Ethiopia: A community-based cross-sectional study.

Authors:  Abebe Sorsa Badacho; Mengistu Auro Lelu; Zegeye Gelan; Deginesh Dawit Woltamo
Journal:  PLoS One       Date:  2022-01-21       Impact factor: 3.240

10.  Depression among women with obstetric fistula, and pelvic organ prolapse in northwest Ethiopia.

Authors:  Berihun Megabiaw Zeleke; Tadesse Awoke Ayele; Mulatu Adefris Woldetsadik; Telake Azale Bisetegn; Akilew Awoke Adane
Journal:  BMC Psychiatry       Date:  2013-09-26       Impact factor: 3.630

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.